Wei Zheng
MD, PhD; Editor in Chief, Alpha Psychiatry; Department of Psychiatry, The Affiliated Brain Hospital of Guangzhou Medical University
Key Impact
He is a clinician-researcher publishing influential clinical studies on repeated intravenous ketamine for depression, including anhedonia, suicidality, cognition, and biomarkers like BDNF and VEGF.
Background & Research
Wei Zheng is a psychiatrist and researcher based at The Affiliated Brain Hospital of Guangzhou Medical University in Guangzhou, China. His work has focused on ketamine treatment for treatment-resistant depression and related outcomes such as anhedonia, cognition, suicidal ideation, and biomarker responses. He also serves as Editor in Chief of Alpha Psychiatry.
Collaboration Network
6 collaborators· click a node to visit their profile
Full network →